UNSPSC 85533219: Insertion of intraluminal device into colic vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of intraluminal device into colic vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06H73DZ

UNSPSC 85533219 Insertion of intraluminal device into colic vein, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six recent opportunities posted under this code—independent medical evaluation services (City of Phoenix), surgical benefit carve-out programs (City of Long Beach), occupational medical surveillance (Washington State Department of Transportation), emergency and specialty medical services for detained youth (Harris County), pharmacy benefit management (Collier County), and temporary health professional staffing (County of Santa Clara)—are administrative, occupational health, and clinical staffing services that bear no relation to the code's nominal scope of intraluminal vascular device insertion. The code appears to describe a specific interventional radiology procedure, yet the actual opportunities solicited are for broader healthcare administration, benefit management, and personnel services entirely unrelated to device-based vascular intervention.

Given the fundamental mismatch between the code taxonomy and the work actually being bought, this code does not represent a viable procurement opportunity for vendors offering intraluminal device insertion services, vascular intervention supplies, or related clinical products. The recent activity reflects either tagging error or jurisdictional misapplication of UNSPSC classification. Business development professionals pursuing vascular device or interventional radiology work should not use this code as a market signal and should verify coding against clinical procurement RFPs directly.